These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 3050029)
21. Effect of clonidine on tyrosine hydroxylase activity in the adrenal medulla and brain of spontaneously hypertensive rats. Moura E; Afonso J; Serrão MP; Vieira-Coelho MA Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):113-21. PubMed ID: 19067675 [TBL] [Abstract][Full Text] [Related]
22. The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats. Anderson IK; Drew GM Br J Pharmacol; 1998 Nov; 125(6):1236-46. PubMed ID: 9863652 [TBL] [Abstract][Full Text] [Related]
23. [Effect of moxonidine on the cardiac chronotropic regulation in hypertensive rats SHR-SP]. Khokhlova ON; Murashov AN; Lavrova LN; Medvedev OS Eksp Klin Farmakol; 2001; 64(1):42-5. PubMed ID: 11544803 [TBL] [Abstract][Full Text] [Related]
24. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine. Moreira TS; Takakura AC; Menani JV; Colombari E Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316 [TBL] [Abstract][Full Text] [Related]
25. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats. El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461 [TBL] [Abstract][Full Text] [Related]
26. Antihypertensive responses elicited by central moxonidine in rats: possible role of nitric oxide. Moreira TS; Takakura AC; Sato MA; Menani JV; Colombari E J Cardiovasc Pharmacol; 2006 Jun; 47(6):780-7. PubMed ID: 16810079 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of a novel antihypertensive agent, LY127210, in anesthetized and conscious spontaneously hypertensive rats. Ruffolo RR; Kurz K; Paget CJ J Pharmacol Exp Ther; 1985 Jan; 232(1):134-8. PubMed ID: 3838104 [TBL] [Abstract][Full Text] [Related]
28. Flavodilol: a new antihypertensive agent. Kinsolving CR; Watkins BE; Borrelli AR; Kaiser FC; Wu ES J Cardiovasc Pharmacol; 1989 Jul; 14(1):127-41. PubMed ID: 2475704 [TBL] [Abstract][Full Text] [Related]
29. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats. Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of the antihypertensive action of DL-alpha-monofluoromethyldopa: implications for the role of the sympathetic nervous system in maintenance of elevated blood pressure in spontaneously hypertensive rats. Fozard JR; Möhring J; Palfreyman MG; Koch-Weser J J Cardiovasc Pharmacol; 1981; 3(5):1038-49. PubMed ID: 6168849 [TBL] [Abstract][Full Text] [Related]
31. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats. Mervaala EM; Malmberg L; Teräväinen TL; Laakso J; Vapaatalo H; Karppanen H Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606 [TBL] [Abstract][Full Text] [Related]
32. Effects of urapidil on blood pressure and adrenoceptors in various animal models. van Zwieten PA; Mathy MJ; Thoolent MJ; Wilffert B; de Jonge A; Timmermans PB J Hypertens Suppl; 1984 Dec; 2(3):S539-41. PubMed ID: 6599713 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models. Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773 [TBL] [Abstract][Full Text] [Related]
34. Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine β-hydroxylase inhibitor. Igreja B; Wright LC; Soares-da-Silva P J Am Soc Hypertens; 2016 Mar; 10(3):207-16. PubMed ID: 26803288 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat. Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats. Lefevre-Borg F; Lorrain J; Lechaire J; Thiry C; Lhoste F; Hicks PE; Cavero I Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767 [TBL] [Abstract][Full Text] [Related]
37. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat. Van der Niepen P; Schoors DF; Dupont AG Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774 [TBL] [Abstract][Full Text] [Related]
38. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits. Ensinger H; Majewski H; Hedler L; Starke K J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590 [TBL] [Abstract][Full Text] [Related]
39. Concentration-dependent, stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with the peptidoleukotriene receptor antagonist SK & F 104353. Smith EF; Kinter LB; Jugus M; Eckardt RD; Newton JF Eicosanoids; 1989; 2(2):101-7. PubMed ID: 2560662 [TBL] [Abstract][Full Text] [Related]
40. Role of the central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. Kiritsy-Roy JA; Halter JB; Gordon SM; Smith MJ; Terry LC J Pharmacol Exp Ther; 1990 Oct; 255(1):154-60. PubMed ID: 2213551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]